Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MRNA Moderna	$47.19 -0.8%	$50.24	$22.28 ▼ $59.55	$18.88B	1.05	7.61 million shs	6.31 million shs
SNDK Sandisk	$1,694.98 +3.2%	$1,073.33	$36.21 ▼ $1,708.83	$243.11B	4.82	14.16 million shs	8.71 million shs
SPY SPDR S&P 500 ETF Trust	$756.48 +0.2%	$702.90	$583.23 ▼ $758.08	$774.70B	1	74.45 million shs	54.92 million shs
TPL Texas Pacific Land	$392.54 -2.2%	$434.42	$269.23 ▼ $547.20	$27.68B	0.66	368,190 shs	1.34 million shs
XLV Health Care Select Sector SPDR Fund	$149.47 -0.9%	$146.52	$127.96 ▼ $160.59	$39.18B	0.58	12.61 million shs	13.20 million shs

7 Stocks to Ride The A.I. Megaboom

We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MRNA Moderna	-0.80%	+0.66%	+3.22%	-11.91%	+81.15%
SNDK Sandisk	+3.25%	+14.63%	+59.27%	+166.77%	+4,339.44%
SPY SPDR S&P 500 ETF Trust	+0.25%	+1.45%	+6.31%	+10.28%	+28.71%
TPL Texas Pacific Land	-2.19%	-2.57%	-10.55%	-25.13%	-3.52%
XLV Health Care Select Sector SPDR Fund	-0.93%	-0.28%	+4.64%	-6.70%	+13.68%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MRNA Moderna	$47.19 -0.8%	$50.24	$22.28 ▼ $59.55	$18.88B	1.05	7.61 million shs	6.31 million shs
SNDK Sandisk	$1,694.98 +3.2%	$1,073.33	$36.21 ▼ $1,708.83	$243.11B	4.82	14.16 million shs	8.71 million shs
SPY SPDR S&P 500 ETF Trust	$756.48 +0.2%	$702.90	$583.23 ▼ $758.08	$774.70B	1	74.45 million shs	54.92 million shs
TPL Texas Pacific Land	$392.54 -2.2%	$434.42	$269.23 ▼ $547.20	$27.68B	0.66	368,190 shs	1.34 million shs
XLV Health Care Select Sector SPDR Fund	$149.47 -0.9%	$146.52	$127.96 ▼ $160.59	$39.18B	0.58	12.61 million shs	13.20 million shs

7 Stocks to Ride The A.I. Megaboom

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MRNA Moderna	-0.80%	+0.66%	+3.22%	-11.91%	+81.15%
SNDK Sandisk	+3.25%	+14.63%	+59.27%	+166.77%	+4,339.44%
SPY SPDR S&P 500 ETF Trust	+0.25%	+1.45%	+6.31%	+10.28%	+28.71%
TPL Texas Pacific Land	-2.19%	-2.57%	-10.55%	-25.13%	-3.52%
XLV Health Care Select Sector SPDR Fund	-0.93%	-0.28%	+4.64%	-6.70%	+13.68%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MRNA Moderna	1.84	Reduce	$35.73	-24.28% Downside
SNDK Sandisk	3.00	Buy	$1,368.73	-19.25% Downside
SPY SPDR S&P 500 ETF Trust	2.82	Moderate Buy	$756.48	N/A
TPL Texas Pacific Land	2.50	Moderate Buy	$639.00	62.79% Upside
XLV Health Care Select Sector SPDR Fund	2.75	Moderate Buy	$149.47	N/A

Current Analyst Ratings Breakdown

Latest MRNA, SPY, SNDK, TPL, and XLV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/29/2026	SNDK Sandisk	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Positive	$2,000.00 ➝ $3,250.00
5/28/2026	SNDK Sandisk	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$1,625.00 ➝ $1,825.00
5/26/2026	SNDK Sandisk	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$1,200.00 ➝ $2,300.00
5/26/2026	MRNA Moderna	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
5/20/2026	SNDK Sandisk	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
5/19/2026	SNDK Sandisk	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$1,300.00 ➝ $2,025.00
5/18/2026	SNDK Sandisk	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$2,350.00
5/6/2026	SNDK Sandisk	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C+)
5/4/2026	MRNA Moderna	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$36.00 ➝ $45.00
5/4/2026	MRNA Moderna	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sector Perform	$35.00 ➝ $38.00
5/4/2026	SNDK Sandisk	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1,700.00

(Data available from 5/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MRNA Moderna	$1.94B	9.63	N/A	N/A	$18.67 per share	2.53
SNDK Sandisk	$7.36B	34.13	$15.99 per share	105.97	$93.03 per share	18.22
SPY SPDR S&P 500 ETF Trust	N/A	N/A	N/A	N/A	N/A	N/A
TPL Texas Pacific Land	$798.19M	33.92	$7.72 per share	50.85	$22.56 per share	17.40
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MRNA Moderna	-$2.82B	-$8.15	N/A	N/A	N/A	-143.55%	-26.64%	-19.32%	7/31/2026 (Estimated)
SNDK Sandisk	-$1.64B	$28.77	58.91	9.43	N/A	34.19%	44.06%	33.63%	N/A
SPY SPDR S&P 500 ETF Trust	N/A	N/A	25.94	N/A	N/A	N/A	N/A	N/A	N/A
TPL Texas Pacific Land	$481.38M	$7.30	53.77	38.33	N/A	60.03%	35.52%	31.95%	8/5/2026 (Estimated)
XLV Health Care Select Sector SPDR Fund	N/A	N/A	21.15	N/A	N/A	N/A	N/A	N/A	N/A

Latest MRNA, SPY, SNDK, TPL, and XLV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2026	Q1 2026	TPL Texas Pacific Land	$2.03	$2.07	+$0.04	$2.07	$233.00 million	$236.80 million
5/1/2026	Q1 2026	MRNA Moderna	-$3.02	-$3.40	-$0.38	-$3.40	$236.37 million	$389.00 million
4/30/2026	Q3 2026	SNDK Sandisk	$14.17	$23.41	+$9.24	$23.03	N/A	$5.95 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MRNA Moderna	N/A	N/A	N/A	N/A	N/A
SNDK Sandisk	N/A	N/A	N/A	N/A	N/A
SPY SPDR S&P 500 ETF Trust	$7.38	0.98%	N/A	N/A	N/A
TPL Texas Pacific Land	$2.40	0.61%	-5.92%	32.88%	3 Years
XLV Health Care Select Sector SPDR Fund	$2.50	1.67%	N/A	N/A	N/A

Latest MRNA, SPY, SNDK, TPL, and XLV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/5/2026	TPL Texas Pacific Land	quarterly	$0.60	0.57%	6/1/2026	6/1/2026	6/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MRNA Moderna	0.08	2.41	2.35
SNDK Sandisk	N/A	4.78	3.62
SPY SPDR S&P 500 ETF Trust	N/A	N/A	N/A
TPL Texas Pacific Land	N/A	11.05	11.05
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MRNA Moderna	75.33%
SNDK Sandisk	N/A
SPY SPDR S&P 500 ETF Trust	63.54%
TPL Texas Pacific Land	59.94%
XLV Health Care Select Sector SPDR Fund	N/A

Insider Ownership

Company	Insider Ownership
MRNA Moderna	10.80%
SNDK Sandisk	0.21%
SPY SPDR S&P 500 ETF Trust	N/A
TPL Texas Pacific Land	6.90%
XLV Health Care Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MRNA Moderna	4,700	396.79 million	353.93 million	Optionable
SNDK Sandisk	11,000	148.09 million	147.78 million	Not Optionable
SPY SPDR S&P 500 ETF Trust	N/A	1.02 billion	N/A	Not Optionable
TPL Texas Pacific Land	100	68.97 million	64.22 million	Not Optionable
XLV Health Care Select Sector SPDR Fund	N/A	262.11 million	N/A	Not Optionable

MRNA, SPY, SNDK, TPL, and XLV Headlines

Recent News About These Companies

Health Care Select Sector SPDR Fund (NYSEARCA:XLV) Share Price Passes Below 200-Day Moving Average - Time to Sell?

May 29 at 3:43 AM | americanbankingnews.com

Sickly healthcare stocks are perking up. For contrarian investors, buying now could be just the remedy to protect your portfolio

May 25, 2026 | msn.com

Health Care Select Sector SPDR Fund (NYSEARCA:XLV) Shares Pass Below Two Hundred Day Moving Average - Here's Why

May 21, 2026 | americanbankingnews.com

State Street Health Care Select Sector SPDR ETF (XLV)

May 20, 2026 | finance.yahoo.com

When 2022 Tore Through the S&P 500, This Healthcare ETF Barely Flinched. Why Isn’t It in More Retirement Accounts?

May 20, 2026 | finance.yahoo.com

When 2022 Tore Through the S&P 500, This Healthcare ETF Barely Flinched. Why Isn't It in More Retirement Accounts?

May 20, 2026 | 247wallst.com

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

May 19, 2026 | 247wallst.com

These Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)

...

May 18, 2026 | marketbeat.com

Why the Healthcare Sector Warrants Concentrated Exposure

May 13, 2026 | etftrends.comE

April Jobs Data Put Focus on These Sector ETFs & Stocks

May 13, 2026 | zacks.com

Weekly ETFs: Eight of 11 sectors record outflows; financial sector leads inflows

May 5, 2026 | seekingalpha.com

Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard

May 3, 2026 | seekingalpha.com

Healthcare’s Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026

April 29, 2026 | aol.comA

Healthcare's Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026

April 29, 2026 | 247wallst.com

When the Market Sold Off in 2022, This Healthcare ETF Beat the S&P 500 by 16 Percentage Points. With Volatility Back, That History Is Worth Revisiting

April 25, 2026 | 247wallst.com

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?

April 20, 2026 | zacks.com

What Johnson & Johnson Earnings Signal for Healthcare ETFs

April 14, 2026 | etftrends.comE

Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings

April 10, 2026 | msn.com

Likely Sector ETF & Stock Winners From March Jobs Report

April 6, 2026 | zacks.com

Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags

April 1, 2026 | msn.com

Consumer Sentiment Weakens: ETFs That Are Worth a Look

April 1, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MRNA, SPY, SNDK, TPL, and XLV Company Descriptions

Moderna NASDAQ:MRNA

$47.19 -0.38 (-0.80%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$47.36 +0.17 (+0.35%)

As of 05/29/2026 08:00 PM Eastern

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Sandisk NASDAQ:SNDK

$1,694.98 +53.34 (+3.25%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$1,683.52 -11.46 (-0.68%)

As of 05/29/2026 07:59 PM Eastern

SanDisk Corporation offers flash storage solutions. The Company designs, develops and manufactures data storage solutions in a range of form factors using flash memory, controller, firmware and software technologies. The Company operates through flash memory storage products segment. Its solutions include a range of solid state drives (SSD), embedded products, removable cards, universal serial bus (USB), drives, wireless media drives, digital media players, and wafers and components. It offers SSDs for client computing applications, which encompass desktop computers, notebook computers, tablets and other computing devices. Its embedded products are used for embedded storage for mobile phones, tablets, notebooks and other portable and wearable devices, as well as in automotive and connected home applications. Its removable products include cards, USB flash drives, Wireless Drives and Digital Media Players at a range of storage capacities. It sells memory wafers and memory components.

SPDR S&P 500 ETF Trust NYSEARCA:SPY

$756.48 +1.88 (+0.25%)

Closing price 05/29/2026 04:10 PM Eastern

Extended Trading

$755.70 -0.78 (-0.10%)

As of 05/29/2026 07:59 PM Eastern

SPDR S&P 500 ETF Trust (the Trust) is a unit investment trust. The Trust seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index (the Index). The Trust seeks to achieve this investment objective by holding a portfolio of the common stocks that are included in the Index (the Portfolio), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the Index. The Trust invests in a range of sectors, including pharmaceuticals; oil, gas and consumable fuels; technology hardware storage and peripherals; insurance; information technology (IT) services; healthcare providers and services; semiconductors and semiconductor equipment; hotels, restaurants and leisure, communications equipment; commercial services and supplies; road and rail; real estate management and development; containers and packaging; professional services, and paper and forest products.

Texas Pacific Land NYSE:TPL

$392.54 -8.78 (-2.19%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$394.75 +2.21 (+0.56%)

As of 05/29/2026 07:51 PM Eastern

Texas Pacific Land Corporation engages in the land and resource management, and water services and operations businesses. The company owns a 1/128th nonparticipating perpetual oil and gas royalty interest (NPRI) under approximately 85,000 acres of land; a 1/16th NPRI under approximately 371,000 acres of land; and approximately 4,000 additional net royalty acres, total of approximately 195,000 NRA located in the western part of Texas. The Land and Resource Management segment manages surface acres of land, and oil and gas royalty interest in West Texas. This segment also engages in easements, such as transporting oil, gas and related hydrocarbons, power line and utility, and subsurface wellbore easements. In addition, this segment leases its land for processing, storage, and compression facilities and roads; and is involved in sale of materials, such as caliche, sand, and other material, as well as sells land. The Water Services and Operations segment provides full-service water offerings, including water sourcing, produced-water treatment, infrastructure development, and disposal solutions to operators in the Permian Basin. This segment also holds produced water royalties. Texas Pacific Land Corporation was founded in 1888 and is headquartered in Dallas, Texas.

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$149.47 -1.41 (-0.93%)

Closing price 05/29/2026 04:10 PM Eastern

Extended Trading

$149.28 -0.19 (-0.13%)

As of 05/29/2026 07:58 PM Eastern

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MRNA, SPY, SNDK, TPL, and XLV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MRNA, SPY, SNDK, TPL, and XLV Earnings

Compare Dividends

Latest MRNA, SPY, SNDK, TPL, and XLV Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MRNA, SPY, SNDK, TPL, and XLV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MRNA, SPY, SNDK, TPL, and XLV Company Descriptions

Moderna NASDAQ:MRNA

Sandisk NASDAQ:SNDK

SPDR S&P 500 ETF Trust NYSEARCA:SPY

Texas Pacific Land NYSE:TPL

Health Care Select Sector SPDR Fund NYSEARCA:XLV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools